Renal allograft failure predictors after pak transplantation: Results from the new England collaborative association of pancreas programs

Transplantation

Volumn 89, Issue 11, 2010, Pages 1347-1353

  Pavlakis, Martha ^a   Khwaja, Khalid ^b   Mandelbrot, Didier ^a   Tang, Hongying ^a   Whiting, James W ^c   Lorber, Marc I ^d,e   Gautam, Amitabh ^f   Johnson, Scott R ^a   Uknis, Marc E ^g,h  

^a Transplant Center   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c MAINE MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f BOSTON MEDICAL CENTER   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h ViroPharma Incorporated   (United States)

Author keywords

Immunosuppression.; Kidney allograft failure; Kidney rejection; Pancreas transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DYSFUNCTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; UNITED STATES;

ADULT; ANTILYMPHOCYTE SERUM; BODY WEIGHT; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77953358734     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d84c48     Document Type: Article

References (12)

1. Ojo A, Meier-Kriesche H-U, Hanson J, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82.
2. American Diabetes Association. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2004; 27(suppl 1):S105.
3. SRTR website: www.ustransplant.org/2008 table 7.16. Accessed on May 26, 2009.
4. Wolfe R, Ashby V, Milford E, et al. Comparison of mortality in all patients on dialysis, patients awaiting transplantation, and recipients of a first caadaveric transplant. N Engl J Med 1999; 341: 1725.
5. Scalea J, Butler C, Munivenkatappa R, et al. Pancreas transplant alone as an independent risk factor for the development of renal failure: A retrospective study. Transplantation 2008; 86: 1789.
6. Mazur M, Rea D, Griffin M, et al. Decline in native renal function early after bladder-drained pancreas transplatnation alone. Transplantation 2004; 77: 844.
7. Levey AS, Greene T, Schlucter MD, et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993; 4: 1159.
8. Larson T, Bohorquez H, Rea D, et al. Pancreas-after-kidney transplantation: An increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation 2004; 77: 838.
9. IPTR website: www.iptr.umn.edu/. Accessed May 26, 2009.
10. Hariharan S,PirschJ, LuC, et al. Pancreas after kidney transplantation. J Am Soc Nephrol 2002; 13: 1109.
11. Lipshutz G, Pham P, Ghobrial M, et al. Thrombotic microangiopathy following pancreas after kidney transplants. Clin Transplant 2008; 22: 236.
12. Fioretto P, Steffes MW, Sutherland DER, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69.